Advertisement

Comparing Long-Term Sequelae of the Systemic Right Ventricle: An Overview of Single Versus Biventricular Arrangements

  • Stephanie Fuller
    Correspondence
    Address correspondence to: Stephanie Fuller, MD, Division of Cardiothoracic Surgery, The Children's Hospital of Philadelphia, 3401 Civic Center Blvd., Suite M875, Philadelphia, PA 19104.
    Affiliations
    Division of Cardiothoracic Surgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    Search for articles by this author
      Patients with systemic right ventricles (RV) are at risk for heart failure and sudden cardiac death. Contributing factors to RV dysfunction include increased afterload from the systemic circulation, coronary insufficiency, progressive tricuspid valve regurgitation, the presence of residual lesions after palliation and arrhythmias. While all patients with a systemic right ventricle (SRV) are vulnerable to heart failure, there are distinct differences between patients with congenital dextro-transpostion of the great arteries (d-TGA) repaired by atrial switch, unrepaired congenitally corrected transposition of the great arteries (cc-TGA) and single systemic right ventricles palliated with a Fontan operation. Herein, we explore both the similarities and differences in progression of heart failure by phenotype as well as both the advancements and limitations in treatment options by each type of SRV.

      Keywords

      Abbreviations:

      RV (Right ventricle), LV (Left ventricle), SRV (Systemic right ventricle), ccTGA (Congenitally Corrected Transposition of the Great Arteries), dTGA (Dextrotransposition of the Great Arteries), NYHA (New York Heart Association)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Brida M
        • Diller G
        • Gatzoulis MA.
        Systemic right ventricle ein adults with congenital heart disease.
        Circulation. 2018; 137: 508-518
        • Senning A.
        Surgical correction of transposition of the great vessels.
        Surgery. 1959; 45: 966-980
        • Mustard WT.
        Successful two-stage correction of transposition of the great vessels.
        Surgery. 1964; 55: 469-472
        • Atallah J
        • Rutledge JM
        • Dyck JD.
        Congenitally corrected transposition of the great arteries (Atrioventricular and Ventriculoarterial discordance.
        in: Allen RES Hugh D Dricoll David J. Feltes Timothy F. Moss and Adams’ Heart Disease in Infants, Children and Adolescents, Vol II. 8th Ed. Lippincott Williams & Wilkins, Philadelphia, Pennsylvania2013: 1147-1160
        • Andrade L
        • Carazo M
        • Wu F
        • et al.
        Mechanisms for heart failure in systemic right ventricle.
        Heart Fail Rev. 2020; 25: 599-607
        • Daminao RJ
        • La Follette P
        • Cox JL
        • et al.
        Significant left ventricular contribution to right ventricular systelic function.
        Am J Phys. 1991; 261: H1514-H1524
        • Dos-Subira L.
        Failing systemic right ventricle: To treat or not to treat.
        Heart. 2021; 107: 1360-1361
        • Connelly MS
        • Liu PP
        • Williams WG
        • et al.
        Congenitally corrected transposition of the great arteries in the adult: Functional status and complications.
        J Am Coll Cardiol. 1996; 27: 1238-1243
        • Campanale CM
        • Scherrer B
        • Afacan O
        • et al.
        Myofiber organization in the failing systemic right ventricle.
        J Cardiovasc Magn Reson. 2020; 22: 1-13
        • Diller GP
        • Kempny A
        • Alonso-Gonzalez R
        • et al.
        Contemporary adult congenital heart disease patietns under follow-up at a large tertiary centre.
        Circulation. 2015; 132: 2118-2125
        • Vejlstrup N
        • Sorensen K
        • Mattsson E
        • et al.
        Long-term outcome of Mustard/Senning correction for transposition of the great arteries in Sweden and Denmark.
        Circulation. 2015; 132: 633-638
        • Prieto LR
        • Hordof AH
        • Secic M
        • et al.
        Progressive tricuspid valve disease in patients with congenitally corrected transposition of the great arteries.
        Circulation. 1998; 96: 997-1005
        • Iyengar AJ
        • Winlaw DS
        • Glati JC
        • et al.
        The extracardiac conduit Fontan procedure in Australia and New Zealand: Hypoplastic left heart syndrome predicts worse early and late outcomes.
        Eur J Cardiothorac Surg. 2014; 46: 465-473
        • Kawahira Y
        • Uemura H
        • Yoshikawa Y
        • et al.
        Double inlet right ventricle versus other types of double or common inlet ventricle: Its clinical characteristics with reference to the Fontan procedure.
        Eur J Cardiothorac Surg. 2001; 20: 228-232
        • Cuypers JA
        • Eindhoven JA
        • Slager MA
        • et al.
        The natural and unnatural history of the Mustard procedure: Long-term outcome up to 40 years.
        Eur Heart J. 2014; 35: 1666-1674
        • Graham TP
        • Bernard YD
        • Mellen BG
        • et al.
        Long-term outcome in congenitally corrected transposition of the great arteries: A multi-institutional study.
        J Am Coll Cardiol. 2000; 36: 255-261
        • Moon J
        • Shen L
        • Likosky DS
        • et al.
        Relationship of ventricular morphology and atrioventricular valve function to long-term outcomes following Fontan procedures.
        JACC. 2020; 76: 419-430
        • Mongeon FP
        • Connolly HM
        • Dearani JA
        • et al.
        Congenitally corrected transposition of the great arteries: Ventricular function at the time of systemic atrioventricular valve replacement predicts long-term ventricular function.
        JACC. 2011; 57: 2008-2017
        • Tseng SY
        • Siddiqui S
        • Di Maria MV
        • et al.
        Atrioventricular valve regurgitation in single ventricle heart disease: A common problem associated with progressive deterioration and mortality.
        J Am Heart Assoc. 2020; 9: 1-12
        • King G
        • Ayer J
        • Celermajer D
        • et al.
        Atrioventricular valve failure in Fontan palliation.
        J Am Coll Cardiol. 2019; 73: 810-822
        • Muntaner CD
        • King G
        • Zannino D
        • et al.
        Poor late outcomes after tricuspid valve repair in a single ventricle experience of 103 patients.
        Ann Thorac Surg. 2021; 101: 987-994
        • Khairy P
        • Van Hare GF
        • Balaji S
        • et al.
        PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the Euro- pean Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).
        Heart Rhythm. 2014; 11: e102-e165https://doi.org/10.1016/j. hrthm.2014.05.009
        • Kharbanda RK
        • Moore JP
        • Taverne YJHJ
        • et al.
        Cardiac resynchronization therapy for the failing systemic right ventricle: A systematic review.
        Int J Cardiol. 2020; : 74-81
        • Zaragoza-Macias E
        • Zaidi AN
        • Dendukuri N
        • et al.
        Medical therapy for systemic right ventricles: A systematic review (Part1) for the 2018 AHA/ACC Guideline for the Management of Adults with Congential Heart Disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        Circulation. 2019; 139: e801-e813
        • Ladouceur M
        • Segura de la Cal T
        • Gaye B
        • et al.
        Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle.
        Heart. 2021; 107: 1384-1389
        • Menachem JN
        • Schlendorf KH
        • Mazurek JA
        • et al.
        Advanced heart failure in adutls with congenital heart disease.
        J Am Coll Cardiol. 2020; 8: 87-99
        • Cedars A
        • Kutty S
        • Danford D
        • et al.
        Systemic ventricular assist device support in Fontan patients: A report by ACTION.
        J Heart Lung Transplant. 2021; 40: 368-376
        • Bedzra EK
        • Adachi K
        • Peng DM
        • et al.
        Systemic ventricular assist device support of the Fontan circulation yields promising outcomes: An analysis of the Society of Thoracic Surgeons Pedimacs and Intermacs Databases.
        J Thorac Cardiovasc Surg. 2021; (2021 Nov 27;S0022-5223(21)01677-9. Epub ahead of print)
        • Assenza GE
        • Graham DA
        • Landzberg MJ
        • et al.
        MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
        Heart. 2013; 99: 491-496
        • Doumouras BS
        • Alba AC
        • Foroutan F
        • et al.
        Outcomes in adult congenital heart disease patients undergoing heart transplantation: A systematic review and meta-analysis.
        J Heart Lung Transplant. 2016; 35: 1337-1347
      1. Criteria Requirements in Adult Heart Allocation Policy. Available at: https://optn.transplant.hrsa.gov/media/2413/adult_heart_criteria.pdf.

        • Tobler D
        • Bouchardy J
        • Reto E
        • et al.
        Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right Ventricular size and function – A multi-center, double-blinded, randomized, placebo-controlled clinical trial – SERVE trial- Rational and design.
        Int J Cardiol. 2017; 243: 354-359
        • Goldberg DJ
        • Zak V
        • Goldstein BH
        • et al.
        Results of the FUEL Trial.
        Circulation. 2020; 141: 641-651
        • Haller C
        • Friedberg MK
        • Laflamme MA.
        The role of regenerative therapy in the treatment of right ventricular failure: A literature review.
        Stem Cell Res Ther. 2020; 11: 502
        • Si M
        • Ohye RG
        Stem cell therapy for the systemic right ventricle.
        Expert Rev Cardiovasc Ther. 2017; 15: 813-823
        • Ferrari MR
        • DiMaria MV
        • Jacot JG.
        Review on mechanical support and cell-based therapies for the prevention and recovery of the failed Fontan-Kreutzer circulation.
        Front Pediatr. 2021; 8627660